Who is sponsoring NCT04288193?

NCT04288193 is sponsored by Tabula Rasa HealthCare.

What drugs are being tested in NCT04288193?

Interventions in NCT04288193: Recommendation to Deprescribe.

What condition does NCT04288193 study?

NCT04288193 studies Behavioral and Psychiatric Symptoms of Dementia, Insomnia.

Is NCT04288193 still recruiting?

NCT04288193 is currently withdrawn. Last updated 25 May 2022.

Last reviewed 2022-05-25 · How we verify

NCT04288193

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Implementation of a Pharmacist-Driven Antipsychotic Deprescribing Initiative in the PACE Setting: A Pilot Study

Withdrawn Last updated 25 May 2022

What this trial tests

trial testing Recommendation to Deprescribe in Behavioral and Psychiatric Symptoms of Dementia. Withdrawn.

Timeline

19 May 2021

Primary endpoint
18 May 2022

18 May 2022

Quick facts

Lead sponsor	Tabula Rasa HealthCare
Status	Withdrawn
Study type	OBSERVATIONAL
Start date	19 May 2021
Primary completion	18 May 2022
Estimated completion	18 May 2022
Sites	1 location across United States

Drugs / interventions tested

Recommendation to Deprescribe — full drug profile →

Conditions studied

Behavioral and Psychiatric Symptoms of Dementia — all drugs for Behavioral and Psychiatric Symptoms of Dementia →
Insomnia — all drugs for Insomnia →

Sponsor

Tabula Rasa HealthCare — full company profile →

Who can join

55 and older, any sex, with Behavioral and Psychiatric Symptoms of Dementia or Insomnia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this pilot study is to determine the feasibility of implementing an antipsychotic deprescribing initiative that is driven by pharmacists working collaboratively with the Program of All-inclusive Care for the Elderly (PACE) interdisciplinary team.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Recommendation to Deprescribe

Trials testing the same drug.

NCT06804486 — Exercise and Physical Activity in Children With Pediatric Acquired Brain Injury · NA · active not recruiting

Other recruiting trials for Behavioral and Psychiatric Symptoms of Dementia

Currently open trials in the same condition.

NCT07364825 — Acute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient Care · NA · recruiting

Other Tabula Rasa HealthCare trials

Trials by the same sponsor.

NCT05346770 — Pharmacist-led Interventions to Improve Medication Use · unknown
NCT05053815 — Pharmacogenomic Testing in a Program of All-inclusive Care for the Elderly (PACE) Setting · unknown
NCT05053828 — Type 2 Diabetes With Antiplatelet Drugs · completed
NCT04984538 — Implementation of a Pharmacist-led Pharmacogenomic Clinical Service · withdrawn
NCT04971902 — Pharmacist-led Pharmacogenomic Clinical Service Within the Program of All-inclusive Care for the Elderly · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04288193 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tabula Rasa HealthCare
Last refreshed: 25 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04288193.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing